5.59
0 (0%)
5.59
0 (0%)
ChartMill assigns a Buy % Consensus number of 73% to ATRS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.07. This target is 8.57% above the current price.
ATRS was analyzed by 12 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about ATRS.
In the previous month the buy percentage consensus was at a similar level.
ATRS was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-04-14 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2022-04-14 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2022-04-14 | Truist Securities | Downgrade | Buy -> Hold |
| 2022-04-14 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-04-14 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-11-05 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-16 | Truist Securities | Initiate | Buy |
| 2021-05-10 | HC Wainwright & Co. | Maintains | Buy |
ANTARES PHARMA INC / ATRS FAQ
What do analysts expect the price target to be for ANTARES PHARMA INC (ATRS)?
12 analysts have analysed ATRS and the average price target is 6.07 null. This implies a price increase of 8.57% is expected in the next year compared to the current price of 5.59.
How do analysts rate ANTARES PHARMA INC (ATRS)?
The consensus rating for ANTARES PHARMA INC (ATRS) is 73.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.